title: Blood group determinates incidence for pancreatic cancer in Germany.
abstract: BACKGROUND
  Genetic risk factors for sporadic pancreatic cancer are largely unknown but actually under high exposure. Findings of correlations between the AB0 blood group system (Chromosome 9q34,1-q34,2) and the risk of pancreatic cancer (PC) in patients from Asia, America and south Europe have already been published. So far it is unclear, whether this correlation between blood group an PC incidence can be found in German patients as well.
  
  
  METHODS
  One hundred and sixty-six patients who underwent a resection of PC were evaluated in a period between 2000 and 2010. Blood group reference distribution for the German population is given as: 0: 41%; A: 43%; B: 11%; AB: 5%; Rhesus positive: 85%; Rhesus negative: 15%. Analyses were done using the non-parametric Chi(2)-test (p-value two sided; SPSS 19.0).
  
  
  RESULTS
  Median age was 62 (34-82) years. Gender: female 73/44%; male: 93/56%. Observed blood group proportions: 0: 43 (25.9%)/A: 94 (56.6%)/B: 16 (9.6%)/AB: 13 (7.8%)/Rhesus positive: 131 (78.9%)/negative: 35 (21.1%). We detected a significant difference to the German reference distribution of the AB0 system (Chi(2) 19.34, df 3, p < 0.001). Rhesus factor has no impact on AB0-distribution (Chi(2) 4.13, df 3, p = 0.25), but differs significantly from reference distribution-probably due to initial AB0-variation (Chi(2) 4.82, df 1, p = 0.028). The odds ratio for blood group A is 2.01 and for blood group 0 is 0.5.
  
  
  CONCLUSIONS
  The incidence of PC in the German cohort is highly associated with the AB0-system as well. More patients with blood group A suffer from PC (p < 0.001) whereas blood group 0 was less frequent in patients with PC (p < 0.001). Thus, our findings support the results from other non-German surveys. The causal trigger points of this carcinogenesis correlation are still not known.
authors.affiliation: Department of Hematology/Oncology, Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin Berlin, Germany.
authors.forename: U
authors.initials: U
authors.lastname: Pelzer
authors.forename: F
authors.initials: F
authors.lastname: Klein
authors.forename: M
authors.initials: M
authors.lastname: Bahra
authors.forename: M
authors.initials: M
authors.lastname: Sinn
authors.forename: B
authors.initials: B
authors.lastname: Dörken
authors.forename: P
authors.initials: P
authors.lastname: Neuhaus
authors.forename: O
authors.initials: O
authors.lastname: Meyer
authors.forename: H
authors.initials: H
authors.lastname: Riess
keywords: ABO blood-group system; determination; genome; pancreatic cancer; risk factor